Antiatherosclerotic effects of ACE inhibitors: where are we now?

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Angiotensin-converting enzyme (ACE) inhibitors are widely used for hypertension and heart failure.
• Emerging evidence suggests ACE inhibitors offer significant vascular benefits.
• The renin-angiotensin-aldosterone system is implicated in cardiovascular disease risk.

Purpose of the Study:

• To review the evidence on the vascular effects of ACE inhibitors.
• To explore how ACE inhibition impacts patient outcomes.

Main Methods:

• Review of experimental studies on ACE inhibitors' effects on the arterial wall.
• Analysis of epidemiologic studies linking the renin-angiotensin-aldosterone system to myocardial infarction.
• Examination of clinical trial data on ACE inhibitors' impact on ischemic events and atherosclerosis.

Main Results:

• Experimental studies show ACE inhibitors improve endothelial function and arterial wall health, independent of blood pressure reduction.
• Epidemiologic data link the renin-angiotensin-aldosterone system to increased heart attack risk.
• Clinical trials confirm ACE inhibitors reduce ischemic event risk, enhance endothelial function, and slow atherosclerosis progression.

Conclusions:

• ACE inhibitors provide multifaceted cardiovascular benefits.
• These benefits extend to vascular health, improving endothelial function and retarding atherosclerosis.
• ACE inhibition is crucial for managing cardiovascular diseases and improving patient outcomes.